Executive VP at CONMED (CNMD) awarded 16,926 RSUs in corrected Form 4/A

Rhea-AI Filing Summary

Ferrell John D. reported acquisition or exercise transactions in this Form 4 filing.

CONMED Corporation’s Executive Vice President – HR, John D. Ferrell, reported a compensation-related grant of 16,926 restricted stock units (RSUs). The RSUs were awarded under the company’s 2025 Long-Term Incentive Plan and generally vest over three years, with 33% vesting after one year, another 33% after two years, and 34% after three years.

This amended Form 4 corrects the originally reported grant amount by reflecting an additional special award of 7,644 RSUs on top of the previously reported 9,282 RSUs, bringing the total to 16,926 RSUs tied to an equivalent number of common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ferrell John D.

Role Executive Vice President - HR

Type	Security	Shares	Price	Value
Grant/Award	RSUs (Restricted Stock Units)	16,926	$0.00	--

Holdings After Transaction: RSUs (Restricted Stock Units) — 16,926 shares (Direct)

Footnotes (1)

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ferrell John D.

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FL 33773

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President - HR

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSUs (Restricted Stock Units)	$0	03/02/2026		A		16,926		(1)	03/02/2036	Common Stock	16,926(2)	$0	16,926	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

2. This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted.

	/s/ Thomas Fistek for John D. Ferrell by Power of Attorney	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CONMED (CNMD) report for John D. Ferrell?

CONMED reported that Executive Vice President – HR John D. Ferrell received a grant of 16,926 restricted stock units. These RSUs are a stock-based compensation award linked to an equal number of CONMED common shares under the 2025 Long-Term Incentive Plan.

Why is this CONMED (CNMD) Form 4/A filing an amendment?

The filing is an amendment because it corrects the number of RSUs previously reported. It now shows that a special award of 7,644 RSUs was granted in addition to 9,282 RSUs, resulting in a total of 16,926 restricted stock units awarded to the executive.

How many restricted stock units were ultimately granted to the CONMED (CNMD) executive?

The executive ultimately received 16,926 restricted stock units. This figure combines the originally reported 9,282 RSUs with an additional special award of 7,644 RSUs, as clarified in the amended Form 4/A footnote describing the corrected grant amount.

How do the CONMED (CNMD) RSUs for John D. Ferrell vest over time?

The RSUs generally vest over a three-year period. According to the filing, 33% vest one year after the grant date, another 33% vest in the second year, and the remaining 34% vest in the third year, subject to the plan’s terms and conditions.

What does each CONMED (CNMD) RSU granted to the executive represent?

Each restricted stock unit represents a contingent right to receive one share of CONMED common stock. The units are subject to the company’s 2025 Long-Term Incentive Plan and only convert into shares as they vest over the specified three-year schedule.

Is the CONMED (CNMD) insider transaction a market purchase or sale of shares?

The transaction is a grant of RSUs as compensation, not a market purchase or sale. The RSUs were awarded at no cash exercise price and will convert into common shares only if and when the vesting conditions are satisfied under the incentive plan.